These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 719281)

  • 1. The involvement of 5-hydroxytryptamine and dopamine in the behavioural effects of alpha-methyltryptamine [proceedings].
    Marsden CA
    Br J Pharmacol; 1978 Nov; 64(3):431P. PubMed ID: 719281
    [No Abstract]   [Full Text] [Related]  

  • 2. Specificity of monoamine neurotoxins: rotational responses to dopaminergic agonists after unilateral 6-OHDA and 5,6-DHT lesions of the median forebrain bundle [proceedings].
    Waddington JL; Crow TJ
    Br J Pharmacol; 1977 Mar; 59(3):465P-466P. PubMed ID: 300261
    [No Abstract]   [Full Text] [Related]  

  • 3. Backward walking and circling: a behavioural response to concurrent catecholamine and 5-hydroxytryptamine release [proceedings].
    Curzon G; Fernando JC; Lees AJ
    Br J Pharmacol; 1979 May; 66(1):119P-120P. PubMed ID: 454915
    [No Abstract]   [Full Text] [Related]  

  • 4. Involvement of 5-hydroxytryptamine and dopamine neurones in the behavioural effects of alpha-methylytryptamine.
    Marsden CA
    Neuropharmacology; 1980 Aug; 19(8):691-8. PubMed ID: 6448356
    [No Abstract]   [Full Text] [Related]  

  • 5. Attenuation of conflict behavior with cinanserin, a serotonin antagonist: reversal of the effect with 5-hydroxytryptophan and alpha-methyltryptamine.
    Geller I; Hartmann RJ; Croy DJ; Haber B
    Res Commun Chem Pathol Pharmacol; 1974 Jan; 7(1):165-74. PubMed ID: 4544101
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence for the release of hippocampal 5-hydroxytryptamine by alpha-methyltryptamine [proceedings].
    Marsden CA
    Br J Pharmacol; 1979 Nov; 67(3):438P-439P. PubMed ID: 497560
    [No Abstract]   [Full Text] [Related]  

  • 7. Possible role of brain serotonin and dopamine in controlling male sexual behavior.
    Gessa GL; Tagliamonte A
    Adv Biochem Psychopharmacol; 1974; 11(0):217-28. PubMed ID: 4276859
    [No Abstract]   [Full Text] [Related]  

  • 8. Behavioural changes induced by N,N-dimethyltryptamine in rodents [proceedings].
    Jenner P; Marsden CD; Thanki CM
    Br J Pharmacol; 1978 Jun; 63(2):380P. PubMed ID: 276408
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of insulin on 5-methoxytryptamine-induced wet dog shake behavior in rats.
    Kleinrok Z; Juszkiewicz M
    Pol J Pharmacol Pharm; 1986; 38(5-6):443-8. PubMed ID: 3554184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The behavioural effects of intravenously administered tryptamine in mice.
    Yamada J; Sugimoto Y; Horisaka K
    Neuropharmacology; 1987 Jan; 26(1):49-53. PubMed ID: 3561719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence from behavioural reactions to fenfluramine, 5-hydroxytryptophan, and 5-methoxy-N,N-dimethyltryptamine for differential effects of short-term and long-term lithium on indoleaminergic mechanisms in rats [proceedings].
    Harrison-Read PE
    Br J Pharmacol; 1979 May; 66(1):144P-145P. PubMed ID: 313227
    [No Abstract]   [Full Text] [Related]  

  • 12. On the behavioral and neurochemical actions of 6-hydroxydopa and 5,6-dihydroxytryptamine in rats.
    Richardson JS; Cowan N; Hartman R; Jacobowitz DM
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):29-44. PubMed ID: 4847904
    [No Abstract]   [Full Text] [Related]  

  • 13. A study of the central effects of 5,6-dihydroxytryptamine.
    Longo VG; Scotti de Carolis A; Liuzzi A; Massotti M
    Adv Biochem Psychopharmacol; 1974; 10():109-20. PubMed ID: 4546514
    [No Abstract]   [Full Text] [Related]  

  • 14. Behavioural effects of dopamine and 5-hydroxytryptamine in centrally chemosympathectomized rats.
    Herman ZS; Brus R; Szkilnik R
    Pol J Pharmacol Pharm; 1976; 28(5):463-7. PubMed ID: 1012976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microdialysis in the study of psychostimulants and the neural substrate for reinforcement: focus on dopamine and serotonin.
    Hoebel BG; Hernandez L; Mark GP; Pothos E
    NIDA Res Monogr; 1992; 124():1-34. PubMed ID: 1470207
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of biogenic amines and cyclic nucleotides on rats' bhavior after the chemical serotoninectomy of the central nervous system.
    Brus R; Herman ZS; Szkilnik R; Zabawska J; Bonczek A; Zieliński M; Opiełka L
    Pol J Pharmacol Pharm; 1978; 30(2-3):323-34. PubMed ID: 673931
    [No Abstract]   [Full Text] [Related]  

  • 17. Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems.
    Miczek KA; Fish EW; De Bold JF; De Almeida RM
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):434-58. PubMed ID: 12373445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5,7-Dihydroxytryptamine as a tool for the morphological and functional analysis of central 5-hydroxytryptamine neurons.
    Daly J; Fuxe K; Jonsson G
    Res Commun Chem Pathol Pharmacol; 1974 Jan; 7(1):175-87. PubMed ID: 4811447
    [No Abstract]   [Full Text] [Related]  

  • 19. Interactions of tryptamine analogs with 5-hydroxytryptamine and dopamine in rat striatum in vitro.
    Baker GB; Hiob LE; Martin IL; Mitchell PR; Dewhurst WG
    Proc West Pharmacol Soc; 1980; 23():167-70. PubMed ID: 7403121
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhanced 5-hydroxytryptamine and dopamine-mediated behavioural responses following convulsions--II. The effects of anaesthesia and current conditions on the appearance of enhanced responses following electroconvulsive shock.
    Cowen PJ; Nutt DJ; Green AR
    Neuropharmacology; 1980 Sep; 19(9):901-6. PubMed ID: 7422101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.